Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Ovid Therapeutics Inc. (NASDAQ: OVID)
OVID Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
19.80%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
79.90%
OVID Stock Analysis
OVID
PE Ratio:
OVID
PEG Ratio:
Not Available
OVID
Forward EPS Growth (12 month):
0.00%
OVID
PS Ratio:
44.3
OVID
PSG Ratio:
1.1
OVID
Forward Revenue Growth (12 month):
39.40%
OVID Articles
No data was found